We are live on ! Find out more
VIVO

Meridian Bioscience Inc
VIVO

Delisted

VIVO was delisted on the 30th of January, 2023.

Back to rankings

172 hedge funds and large institutions have $802M invested in Meridian Bioscience Inc in 2016 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 74 increasing their positions, 56 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

126% more call options, than puts

Call options by funds: $2.38M | Put options by funds: $1.05M

32% more repeat investments, than reductions

Existing positions increased: 74 | Existing positions reduced: 56

1% less capital invested

Capital invested by funds: $807M → $802M (-$4.82M)

2% less funds holding

Funds holding: 176 → 172 (-4)

11% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 19

Holders
172
Holders Change
-4
Holders Change %
-2.27%
% of All Funds
4.58%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
74
Reduced
56
Closed
19
Calls
$2.38M
Puts
$1.05M
Net Calls
+$1.33M
Net Calls Change
+$728K

Top Buyers

Rank Fund Capital Flow
1
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$8.27M
2
Norges Bank
Norges Bank
Norway
+$6.96M
3
Robeco Institutional Asset Management
Robeco Institutional Asset Management
Netherlands
+$5.28M
4
BTW
Boston Trust Walden
Massachusetts
+$4.75M
5
FAM
Fred Alger Management
New York
+$4.41M

Top Sellers

Rank Fund Capital Flow
1
Neuberger Berman Group
Neuberger Berman Group
New York
-$11.6M
2
PP
Prudential plc
United Kingdom
-$9.97M
3
Wells Fargo
Wells Fargo
California
-$6.96M
4
FAM
Fenimore Asset Management
New York
-$5.44M
5
WBC
Westpac Banking Corp
Australia
-$4M
Name Holding Trade Value Shares
Change 		Change in
Stake
LTFS
151
Ladenburg Thalmann Financial Services
Florida
$46K +$10.6K +536 +33%
Envestnet Asset Management
152
Envestnet Asset Management
Illinois
$44K +$16.6K +843 +65%
AIM
153
Acrospire Investment Management
Illinois
$43K +$41.4K +2,100 New
LIA
154
LS Investment Advisors
Michigan
$34K +$4.41K +224 +16%
HF
155
Hoxton Financial
West Virginia
$32K – – –
GT
156
Glenmede Trust
Pennsylvania
$24K – – –
Zurich Cantonal Bank
157
Zurich Cantonal Bank
Switzerland
$24K – – –
CG
158
Cutler Group
California
$20K -$27.2K -1,382 -58%
SWA
159
Sutton Wealth Advisors
Florida
$15.1K +$14.5K +735 New
BAM
160
Bruderman Asset Management
New York
$10K -$4.12K -209 -31%
QI
161
QS Investors
New York
$10K +$7.67K +389 +367%
TRCT
162
Tower Research Capital (TRC)
New York
$8K +$197 +10 +3%
VCM
163
Versant Capital Management
Arizona
$7K -$30.4K -1,543 -81%
Geode Capital Management
164
Geode Capital Management
Massachusetts
$6.99K +$84.5K +4,288 +1%
Creative Planning
165
Creative Planning
Kansas
$6K -$14.3K -727 -71%
FIB
166
First Interstate Bank
Montana
$4K – – –
HNB
167
Huntington National Bank
Ohio
$4K – – –
PSC
168
Prentiss Smith & Co
Vermont
$4K – – –
HW
169
Hancock Whitney
Mississippi
$1.59K +$155K +7,866 +11%
QCG
170
Quadrant Capital Group
Ohio
$1K +$1.04K +53 New
TWA
171
TCI Wealth Advisors
Arizona
$1K +$1.28K +65 New
FAM
172
Fenimore Asset Management
New York
– -$5.44M -264,900 Closed
WBC
173
Westpac Banking Corp
Australia
– -$4M -195,000 Closed
PM
174
Penbrook Management
New York
– -$1.01M -49,175 Closed
American Century Companies
175
American Century Companies
Missouri
– -$907K -44,209 Closed
4 5 6
7
8

VIVO Hedge Fund Activity: Q1 2016 in Review

172 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Meridian Bioscience Inc (VIVO) for Q1 2016, worth a combined $802M — down 0.6% from $807M a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of VIVO and 17 opened new positions — a net loss of 2 holders — while 56 trimmed existing stakes and 74 added.

The largest buyer was Acadian Asset Management, adding an estimated $8.27M. The largest seller was Neuberger Berman Group, cutting an estimated $11.6M.

  • 172 institutional investors held Meridian Bioscience Inc (VIVO) as of Q1 2016, down from 176 in Q4 2015.
  • Funds reported $802M of Meridian Bioscience Inc stock for Q1 2016, down 0.6% quarter-over-quarter.
  • 17 funds opened new Meridian Bioscience Inc positions in Q1 2016 and 19 closed out, a net change of -2 holders.
  • The largest Meridian Bioscience Inc buyer in Q1 2016 was Acadian Asset Management, an estimated $8.27M added.
  • The largest Meridian Bioscience Inc seller in Q1 2016 was Neuberger Berman Group, an estimated $11.6M sold.

Based on aggregated 13F filings for Q1 2016.